Experts in clinical drug development
Committed to health and science
At Sinfatin we integrate a diverse group of professionals who are experts in CNS diseases and drug development. We explore already marketed medicines to discover new uses and develop therapeutic solutions to address unmet medical needs, especially for those diseases that affect the CNS.
Sinfatin was founded in 2021 and is headquartered in Toledo. Our company works to transform scientific knowledge into new therapies for people affected by pathologies such as ictus and the spinal cord injury. Our main objective is improve the quality of life of patients through safer, more effective and accessible treatments.
A multidisciplinary team with clinical and scientific experience
Our team is made up of highly qualified professionals in medicine, pharmacy, biology, and clinical management. We combine scientific knowledge with experience in clinical research and regulatory frameworks. This diversity of backgrounds allows us to approach each project with a comprehensive approach, methodological rigor, and commitment to quality, participant safety, and real therapeutic impact.
José Javier Muruzábal Gorri
Founder and Development Director
Director and Founder (Pharmaceutical Innovation Services)
Antonio Oliviero, MD PhD
Our way of working
- We bet on the evidence-based medicine.
- We prioritize the participant safety and data quality during clinical development.
- We collaborate with institutions, research centers, and patient associations.
- We seek clinical and social impact.
What makes us different?
- Focus on the drug repositioning.
- Specific therapeutic guidance for fatigue and related functional symptoms caused by CNS diseases.
- Ability to adapt to clinical and regulatory frameworks.
- Willingness to actively contribute to scientific and social progress.
Mission and vision
Our primary mission is to improve patient care and quality of life by repurposing safe and effective therapies for central nervous system disorders, addressing unmet clinical needs.
We are committed to scientific excellence, ethical research, and the pursuit of treatments that deliver meaningful progress for patients.
We envision becoming a leading force in transforming the treatment landscape for central nervous system diseases, with a particular focus on fatigue and related functional symptoms.
We work to improve the lives of those living with central nervous system disorders by mitigating fatigue due to damage to motor systems.
Our commitment is to move toward more effective, safe, and accessible treatments.
